Legal Representation
Attorney
John L. DuPre'
USPTO Deadlines
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 31, 2012 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 31, 2012 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 4, 2012 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Apr 4, 2012 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Apr 4, 2012 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Oct 4, 2011 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 4, 2011 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 4, 2011 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 4, 2011 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 4, 2011 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 3, 2011 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Apr 27, 2011 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Apr 27, 2011 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Apr 27, 2011 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Oct 27, 2010 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 27, 2010 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 27, 2010 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 27, 2010 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Oct 27, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 18, 2010 | I | PAPER RECEIVED | Loading... | |
| Apr 21, 2010 | GNS2 | O | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | Loading... |
| Apr 21, 2010 | GNSI | S | INQUIRY TO SUSPENSION E-MAILED | Loading... |
| Apr 21, 2010 | CNSI | R | SUSPENSION INQUIRY WRITTEN | Loading... |
| Apr 21, 2010 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Apr 21, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Oct 21, 2009 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 21, 2009 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 21, 2009 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Oct 6, 2009 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Apr 6, 2009 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 6, 2009 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 6, 2009 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 6, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 6, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 6, 2009 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 6, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 17, 2009 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Mar 17, 2009 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 17, 2009 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 16, 2009 | I | PAPER RECEIVED | Loading... | |
| Sep 18, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 18, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 18, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 17, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 12, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
| Jun 11, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Nutritional supplements, namely, a glucose composition for administration and absorption of glucose across oral membranes for raising blood glucose level, weight management, and/or increasing energy; pharmaceutical preparations for the treatment of diabetes, obesity, polycystic ovary disease, pain management and deep venous thrombosis (DVT); vaccines for breast cancer, prostate cancer, H5 influenza, ovarian cancer, melanoma cancer, HIV, and SARS; vaccine diagnostic kit comprised of reagents and assays for use in the early detection and screening of type 1 diabetes; Medical diagnostic test strips, namely, blood glucose test strips for use with blood glucose monitor and meter
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Blood glucose monitor and meter
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Research and development in the field pharmaceutical products, nutritional supplements and beverage products
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of a design of three attached half circles to the left of the words "GENEREX BIOTECHNOLOGY".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
010
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOTECHNOLOGY"